Use of adeno-associated viral vector for delivery of small interfering RNA
- PMID: 12944921
- DOI: 10.1038/sj.onc.1206733
Use of adeno-associated viral vector for delivery of small interfering RNA
Abstract
Post-transcriptional gene silencing by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis of mammalian cells. Delivery of siRNA into mammalian cells is usually achieved via the transfection of double-stranded oligonucleotides or plasmids encoding RNA polymerase III promoter-driven small hairpin RNA. Recently, retroviral vectors have been used for siRNA delivery, which overcome the problem of poor transfection efficiency seen with the plasmid-based systems. However, retroviral vectors have several limitations, such as the need for active cell division for gene transduction, oncogenic potential, low titers and gene silencing. In this report, we have adapted a commercially available adenoassociated virus (AAV) vector for siRNA delivery into mammalian cells. We demonstrate the ability of this modified vector to deliver efficiently siRNA into HeLa S3 cells and downregulate p53 and caspase 8 expression. Our results suggest that AAV-based vectors are efficient vectors for the delivery of siRNA into mammalian cells. Based on the known ability of these vectors to infect both dividing and nondividing cells, their use as a therapeutic tool for the delivery of siRNA deserves further study.
Similar articles
-
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.Gene Ther. 2007 Mar;14(5):459-64. doi: 10.1038/sj.gt.3302878. Epub 2006 Oct 19. Gene Ther. 2007. PMID: 17051250
-
Retroviral delivery of small interfering RNA into primary cells.Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14943-5. doi: 10.1073/pnas.242594499. Epub 2002 Nov 4. Proc Natl Acad Sci U S A. 2002. PMID: 12417750 Free PMC article.
-
Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.Int J Mol Med. 2007 Apr;19(4):705-11. Int J Mol Med. 2007. PMID: 17334648
-
Small interfering RNA for experimental cancer therapy.Curr Opin Mol Ther. 2005 Apr;7(2):114-24. Curr Opin Mol Ther. 2005. PMID: 15844618 Review.
-
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):164-82. doi: 10.1016/j.addr.2007.03.010. Epub 2007 Mar 21. Adv Drug Deliv Rev. 2007. PMID: 17481774 Review.
Cited by
-
Optimal delivery of RNA interference by viral vectors for cancer therapy.Mol Ther. 2023 Nov 1;31(11):3127-3145. doi: 10.1016/j.ymthe.2023.09.012. Epub 2023 Sep 20. Mol Ther. 2023. PMID: 37735876 Free PMC article. Review.
-
RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease.PLoS One. 2013;8(4):e58599. doi: 10.1371/journal.pone.0058599. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577057 Free PMC article.
-
In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer.Cancer Sci. 2013 Dec;104(12):1705-10. doi: 10.1111/cas.12297. Epub 2013 Nov 8. Cancer Sci. 2013. PMID: 24118388 Free PMC article.
-
Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.BMC Cancer. 2009 Mar 30;9:97. doi: 10.1186/1471-2407-9-97. BMC Cancer. 2009. PMID: 19331667 Free PMC article.
-
Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.Bone Res. 2013 Sep 1;1(3):267-281. doi: 10.4248/BR201303005. Bone Res. 2013. PMID: 24761229 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous